| Michelle Binder, DNP | |
|
374th Operational Medical Readiness Squadron, Apo, AP 96326-0015 | |
| (315) 225-3566 | |
| Not Available |
| Full Name | Michelle Binder |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 374th Operational Medical Readiness Squadron, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063902088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | R237740 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Binder, DNP Psc 78 Box 1476, Apo, AP 96326-0015 Ph: () - | Michelle Binder, DNP 374th Operational Medical Readiness Squadron, Apo, AP 96326-0015 Ph: (315) 225-3566 |
News Archive
Researchers at The Ohio State University Comprehensive Cancer Center have discovered that a molecule implicated in leukemia and lung cancer is also important in muscle repair and in a muscle cancer that strikes mainly children.
After comparing two patient cancer registries - one featuring transplant patients and the other the general population - researchers at the University of Cincinnati (UC) have found that transplant patients experience worse outcomes from cancer.
Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from The University of Texas Health Science Center at Houston.
Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.
People with type 1 diabetes are at high risk of developing kidney disease, but no therapies are proven to prevent impaired kidney function in these patients. In the Diabetes Control and Complications Trial (DCCT), Ian de Boer, MD and his team looked to see if intensive diabetes therapy aimed at reducing blood sugar as close to the normal range as possible might protect type 1 diabetics' kidney function. The study's results were presented during the American Society of Nephrology's Annual Kidney Week.
› Verified 4 days ago
Jacqueline Marie Floyd, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group Unit 5142, Kadena Air Base, Apo, AP 96368 Phone: 315-360-4780 | |
Christina M Carter, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 36 Medical Group Andersen Afb, Unit 14010, Apo, AP 96543 Phone: 671-362-3009 | |
Patrick Ryan Lee Kadilak, DNP, NP-C, FNP, CRNA Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Brian D. Allgood Army Community Hospital, Unit #15245; Bldg 3031, Apo, AP 96271 Phone: 315-373-5245 | |
Brittany Elaine King, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 315-630-5429 | |
Tiffany Chance, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group Unit 5142, Apo, AP 96368 Phone: 315-630-4487 | |
Megan Thieme, PNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group, Unit 5142, Apo, AP 96368 Phone: 315-630-4780 |